Upper GI bleed: Diagnostic endoscopy had no effect on rebleeding or mortality
|
|
|
Clinical bottom line (level 1b-)
-
Patients who underwent routine diagnostic endoscopy were not clearly less likely to rebleed or die than those who do not.
|
|
Peterson et al:
The New England Journal of Medicine
1981;
304:
925-929
|
Expires
October 2002
|
The study
Unblinded ?concealed randomised
trial
without
intention-to-treat
Setting: Veteran Affairs hospital, USA
206 patients
(aged
55,
?%
male)
with untreated upper gastrointestinal bleeding (a recent history of haematemesis or melaena documented by a bloody nasogastric aspirate or by a stool sample positive for gross or occult blood)
Excluded if
- condition not stabilised within 6 hours of treatment (presence of fresh blood on gastric lavage, or clinical evidence of hypovolaemia or haematocrit <25%)
- contraindication to endoscopy: uncooperative, presence of myocardial ischaemia, pulmonary or cardiac failure, or evidence of perforated viscus.
- abdominal vascular grafts
Control Group: (n = 100, 100 analysed):
Routine endoscopy within 4 hours of stabilisation
Experimental Group: (n = 106, 106 analysed):
No routine endoscopy.
All patients were treated with antacids hourly for the first 24 hours, then qds for 6 weeks. All patients had an upper GI series within 2 to 4 days of admission.
92% followed for
12
months
Outcome notes:
-
recurrent bleeding
: during hospitalisation
-
complications
: pneumonia, myocardial infarction
The evidence
| Outcome |
Time to outcome |
CER | EER | RRR (95% CI) | ARR (95% CI) | NNT (95% CI) |
| recurrent bleeding
|
4
days |
33 (33%) |
32 (30.19%) |
9% (-37% to
39%) |
2.81% (-9.89% to
15.51%) |
36
(NNT = 10 to infinity;
NNH =
6
to infinity)
|
| death
|
12
months |
11 (11%) |
8 (7.55%) |
31% (-64% to
71%) |
3.45% (-4.48% to
11.38%) |
29
(NNT = 9 to infinity;
NNH =
22
to infinity)
|
| complications
|
4
days |
6 (6%) |
4 (3.77%) |
37% (-116% to
82%) |
2.23% (-3.67% to
38.13%) |
45
(NNT = 12 to infinity;
NNH =
27
to infinity)
|
| GI bleed after discharge from hospital
|
12
months |
6 (6%) |
7 (6.6%) |
-10% (-216% to
62%) |
-0.60% (-7.24% to
6.03%) |
-166
(NNT = 17 to infinity;
NNH =
14
to infinity)
|
Comments
- Patients were randomised in blocks of ten.
- Note that the study excluded the sickest patients - i.e. the ones who might have got most benefit
- The study is too small to exclude any benefit from routine endoscopy. It was also performed before interventional endoscopy was common-place.
Citation
-
Peterson
WL,
Barnett
CC,
Smith
HJ, et al:
Routine endoscopy in upper-gastrointestinal-tract bleeding.
The New England Journal of Medicine
1981;
304:
925-929
Contributor: Chris Ball and Musab Hayatli,
October 1999
Reviewer:
Clinical Question.
| Patient |
upper GI bleed |
| Intervention or Exposure |
endoscopy |
| Outcome |
death, rebleeding |
|
|